3-amino-5-(2,6-dichlorophenyl)-7-methyl-2-phenyl-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-b]pyridin-6-one

ID: ALA5171191

Chembl Id: CHEMBL5171191

PubChem CID: 168268904

Max Phase: Preclinical

Molecular Formula: C19H16Cl2N4O

Molecular Weight: 387.27

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1C(=O)C(c2c(Cl)cccc2Cl)Cc2c1nn(-c1ccccc1)c2N

Standard InChI:  InChI=1S/C19H16Cl2N4O/c1-24-18-13(17(22)25(23-18)11-6-3-2-4-7-11)10-12(19(24)26)16-14(20)8-5-9-15(16)21/h2-9,12H,10,22H2,1H3

Standard InChI Key:  UDPWFZAOHJECTH-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5171191

    ---

Associated Targets(Human)

MKNK2 Tchem MAP kinase-interacting serine/threonine-protein kinase 1/2 (155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 387.27Molecular Weight (Monoisotopic): 386.0701AlogP: 4.06#Rotatable Bonds: 2
Polar Surface Area: 64.15Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.84CX LogP: 4.21CX LogD: 4.21
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.72Np Likeness Score: -0.81

References

1. Bou-Petit E, Hümmer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P, Guijarro PJ, Muñoz MJ, Suarez-Cabrera L, Santamaria A, Estrada-Tejedor R, Borrell JI, Ramón Y Cajal S..  (2022)  Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.,  65  (8.0): [PMID:35417652] [10.1021/acs.jmedchem.1c01941]

Source